{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:45Z","timestamp":1783098465042,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019791","name":"Istanbul Medipol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019791","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Mucormycosis is a rapidly progressive angioinvasive fungal infection with limited large-scale outcome data. We aimed to describe the epidemiology, clinical spectrum, treatment strategies, and predictors of outcomes in adult patients with proven mucormycosis in T\u00fcrkiye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a nationwide, retrospective study of 280 adults diagnosed with proven mucormycosis between 2004 and 2024 across 27 tertiary centers. Case definitions were applied according to the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical characteristics, antifungal management, surgical interventions, and outcomes were systematically analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age of the cohort was 60 years, and diabetes mellitus, frequently complicated by ketoacidosis, was the most common underlying condition. Rhino-orbital-cerebral disease represented the predominant clinical form, whereas pulmonary, gastrointestinal, and disseminated presentations were less frequent but carried less favorable prognoses. Liposomal amphotericin B was the main first-line therapy, often combined with surgery, although antifungal treatment was initiated at a median of five days after symptom onset. Ninety-day mortality was 42.1% by Kaplan\u2013Meier estimation (crude 49.3%) and reached 49.3% (crude 55.0%) at 365 days. Crude mortality was lowest in patients who did not undergo surgery; however, this association was not significant in the time-dependent Cox regression analysis, suggesting confounding by baseline severity. Poor outcomes were associated with corticosteroid exposure, prolonged neutropenia, and neurological manifestations, while a history of sinusitis appeared to be associated with improved survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this multicenter study, survival was mainly determined by host-related factors rather than the choice of antifungal agent. Corticosteroid exposure, prolonged neutropenia, and neurological involvement independently predicted poor outcomes, whereas a prior history of sinusitis was linked to improved survival, likely reflecting earlier diagnosis and intervention. These findings reinforce the need for heightened clinical awareness, rapid recognition, and prompt multidisciplinary management to improve outcomes in patients with mucormycosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-025-05397-x","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:46:04Z","timestamp":1769168764000},"page":"537-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiological profile and clinical outcomes of patients with mucormycosis: the multicenter retromucor study from T\u00fcrkiye (2004\u20132024)"],"prefix":"10.1007","volume":"45","author":[{"given":"Yeliz","family":"\u00c7i\u00e7ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u0131dvan","family":"Dumlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl Zehra","family":"Pirdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne\u015fe","family":"Salto\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recep","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcheyla","family":"K\u00f6m\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyit Ali","family":"B\u00fcy\u00fcktuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Bat\u0131rel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eua","family":"S\u00fcmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazl\u0131m Aktu\u011f","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra \u00c7a\u011fla","family":"Karako\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu \u00c7er\u00e7io\u011flu","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Turun\u00e7","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fin K\u0131l\u0131n\u00e7","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eafak","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket Ert\u00fcrk","family":"\u015eengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagehan Didem","family":"Sar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Alay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Kesmez","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Bayrak","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiye","family":"Yir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcrkkan \u00d6zt\u00fcrk","family":"Kaygusuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclten","family":"\u00dcnl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadide","family":"Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"G\u00fcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Bayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Tahmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ey\u00fcp","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Bahar","family":"O\u011fuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aybike","family":"\u00d6zda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem Akal","family":"Ta\u015fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Demirk\u0131rkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Turun\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Oru\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze Kal\u0131n","family":"\u00dcn\u00fcvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"KL\u0130M\u0130K Fungal Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"5397_CR1","doi-asserted-by":"publisher","unstructured":"Spellberg B, Edwards JE Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556\u2013569. https:\/\/doi.org\/10.1128\/CMR.18.3.556-569.2005","DOI":"10.1128\/CMR.18.3.556-569.2005"},{"key":"5397_CR2","unstructured":"World Health Organization (2022) fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization (Mucormycosis fact sheet). Available from: https:\/\/www.who.int\/india\/home\/emergencies\/coronavirus-disease-(covid-19)\/mucormycosis. Accessed August 2025"},{"issue":"1","key":"5397_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","volume":"5","author":"H Prakash","year":"2019","unstructured":"Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi 5(1):26. https:\/\/doi.org\/10.3390\/jof5010026","journal-title":"J Fungi"},{"key":"5397_CR4","doi-asserted-by":"publisher","unstructured":"Gouzien L, Che D, Cassaing S, French Mycoses Study Group et al (2024) Epidemiology and prognostic factors of mucormycosis in France (2012\u20132022): a cross-sectional study nested in a prospective surveillance programme. The Lancet Regional Health - Europe 45:101010. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101010","DOI":"10.1016\/j.lanepe.2024.101010"},{"issue":"1","key":"5397_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010023","volume":"5","author":"A Serris","year":"2019","unstructured":"Serris A, Danion F, Lanternier F (2019) Disease entities in mucormycosis. J Fungi 5(1):23. https:\/\/doi.org\/10.3390\/jof5010023","journal-title":"J Fungi"},{"issue":"4","key":"5397_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s15010-017-0991-6","volume":"45","author":"E Lin","year":"2017","unstructured":"Lin E, Moua T, Limper AH (2017) Pulmonary mucormycosis: clinical features and outcomes. Infection 45(4):443\u2013448. https:\/\/doi.org\/10.1007\/s15010-017-0991-6","journal-title":"Infection"},{"issue":"2","key":"5397_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","volume":"35","author":"JM Steinbrink","year":"2021","unstructured":"Steinbrink JM, Miceli MH (2021) Mucormycosis. Infect Dis Clin North Am 35(2):435\u2013452. https:\/\/doi.org\/10.1016\/j.idc.2021.03.009","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"5397_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.14740\/gr1662","volume":"16","author":"Y Addasi","year":"2023","unstructured":"Addasi Y, Nguyen AH, Sabri A, Ahmad F, Rangray R, Velagapudi M (2023) Gastrointestinal mucormycosis: a clinical review. Gastroenterol Res 16(5):249\u2013253. https:\/\/doi.org\/10.14740\/gr1662","journal-title":"Gastroenterol Res"},{"issue":"Suppl 1","key":"5397_CR9","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/cid\/cir865","volume":"54","author":"AS Ibrahim","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP (2012) Pathogenesis of mucormycosis. Clin Infect Dis 54(Suppl 1):S16\u2013S22. https:\/\/doi.org\/10.1093\/cid\/cir865","journal-title":"Clin Infect Dis"},{"issue":"12","key":"5397_CR10","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D et al (2019) ECMM\/MSGERC. Global guideline for the diagnosis and management of mucormycosis. Lancet Infect Dis 19(12):e405\u2013e421. https:\/\/doi.org\/10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"5397_CR11","doi-asserted-by":"publisher","unstructured":"Reed C, Bryant R, Ibrahim AS, Edwards JE Jr, Filler SG, Goldberg R, Spellberg B (2008) Combination polyene-caspofungin treatment of rhino\u2010orbital\u2010cerebral mucormycosis. Clin Infect Dis 47(3):364\u2013371. https:\/\/doi.org\/10.1086\/589857","DOI":"10.1086\/589857"},{"issue":"4","key":"5397_CR12","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1473-3099(16)00071-2","volume":"63","author":"FM Marty","year":"2016","unstructured":"Marty FM, Ostrosky-Zeichner L, Cornely OA et al (2016) Isavuconazole for treatment of mucormycosis: a single-arm, open-label trial and case-control analysis. Clin Infect Dis 63(4):e108\u2013e118. https:\/\/doi.org\/10.1016\/S1473-3099(16)00071-2","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5397_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00178-20","volume":"64","author":"T Gebremariam","year":"2020","unstructured":"Gebremariam T, Alkhazraji S, Alqarihi A et al (2020) Fosmanogepix (APX001) is effective in the treatment of pulmonary murine mucormycosis due to Rhizopus arrhizus. Antimicrob Agents Chemother 64(6):e00178-20. https:\/\/doi.org\/10.1128\/AAC.00178-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5397_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 71(6):1367\u20131376. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"issue":"Suppl S29","key":"5397_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020 (EPOS 2020). Rhinology 58(Suppl S29):1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinology"},{"issue":"1","key":"5397_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen SC (2019) The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 25(1):26\u201334. https:\/\/doi.org\/10.1016\/j.cmi.2018.07.011","journal-title":"Clin Microbiol Infect"},{"key":"5397_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jof9080824","volume":"9","author":"F Allaw","year":"2023","unstructured":"Allaw F, Zakhour J, Nahhal SB, Koussa K, Bitar ER, Ghanem A, Elbejjani M, Kanj SS (2023) Mucormycosis: a 14-Year retrospective study from a tertiary care center in Lebanon. J Fungi 9:824. https:\/\/doi.org\/10.3390\/jof9080824","journal-title":"J Fungi"},{"key":"5397_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1017\/S0950268805004930","volume":"134","author":"MR Al-Ajam","year":"2006","unstructured":"Al-Ajam MR, Bizri AR, Mokhbat J, Weedon J, Lutwick L (2006) Mucormycosis in the eastern mediterranean: a seasonal disease. Epidemiol Infect 134:341\u2013346. https:\/\/doi.org\/10.1017\/S0950268805004930","journal-title":"Epidemiol Infect"},{"issue":"9","key":"5397_CR19","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(22)00124-4","volume":"22","author":"V Muthu","year":"2022","unstructured":"Muthu V, Agarwal R, Patel A et al (2022) Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the fungal infection study forum. Lancet Infect Dis 22(9):e405\u2013e414. https:\/\/doi.org\/10.1016\/S1473-3099(22)00124-4","journal-title":"Lancet Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05397-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:01:22Z","timestamp":1781629282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05397-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5397"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05397-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Approval No. 1203; 28 November 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Patient consent was waived due to the retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}